BDI-BioEnergy International, which has so far been particularly renowned for the development and construction of BioDiesel plants, is now, together with its 100% subsidiary BDI-BioLife Science GmbH, taking the first step towards implementing an algae technology developed in-house.
The Styrian plant manufacturer BDI - BioEnergy International AG is expanding its presence in the American market by optimising another BioDiesel plant.
BDI – BioEnergy International AG (the “Company”) announces that it was notified by the Frankfurt Stock Exchange (“FSE”) today that, upon application of the Company of December 7, 2016, the admission of its shares (ISIN: AT0000A02177) to trading on the regulated market of the FSE was revoked (“Delisting”). The delisting will become effective upon the end of December 22, 2016. The Company expects that it will not be possible to trade its shares over a stock exchange after this point in time.
On the basis of the voluntary public delisting purchase offer of BDI Beteiligungs GmbH, for which an offer document was published on November 9, 2016, BDI – BioEnergy International AG today applied for the revocation of the admission of its shares to trading in the regulated market of the Frankfurt Stock Exchange ("Delisting"). The acceptance period for the delisting purchase offer of BDI Beteiligungs GmbH expires on December 8, 2016 at 12.00 pm. BDI – BioEnergy International AG expects the delisting to be effective by the end of December 22, 2016
